Glutamine-Dependent Enzyme Regulation in Purine Biosynthesis

Summary

De novo purine biosynthesis begins with the conversion of phosphoribosyl pyrophosphate (PRPP) to phosphoribosylamine, a reaction catalysed by glutamine phosphoribosylpyrophosphate amidotransferase (PPAT). This enzyme harnesses the amide nitrogen of glutamine to initiate the assembly of the purine ring. Its activity is finely tuned by substrate availability and by feedback inhibition from downstream purine nucleotides, notably AMP and GMP. Allosteric transitions between active and inactive conformations underpin cooperative binding and end-product control, ensuring balanced nucleotide pools and preventing wasteful overproduction. Dysregulation of this step has implications for proliferative disorders, immune function and metabolic diseases, making PPAT an attractive target for therapeutic intervention and metabolic engineering.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Glutamine-Dependent Enzyme Regulation in Purine Biosynthesis publication trend

The graph below shows the total number of articles in glutamine-dependent enzyme regulation in purine biosynthesis across all publications each year (not limited to Nature Index journals).

Technical terms

Phosphoribosylpyrophosphate (PRPP): An activated ribose donor that provides the sugar backbone in nucleotide synthesis.

Glutamine phosphoribosylpyrophosphate amidotransferase (PPAT): The enzyme that catalyses the first committed step of de novo purine biosynthesis, using glutamine as a nitrogen donor.

Allosteric regulation: Modulation of enzyme activity through conformational changes induced by ligand binding at sites distinct from the active centre.

Feedback inhibition: A control mechanism in which the end-product of a pathway binds to an upstream enzyme to decrease its activity.

Cooperativity: A phenomenon where binding of a substrate or effector to one site on a multimeric enzyme alters the affinity of additional sites.

References

  1. Glutamine phosphoribosylpyrophosphate amidotransferase from Escherichia coli. Purification and properties.. Journal of Biological Chemistry (1979).
  2. The Interaction of 6-Diazo-5-oxo-l-norleucine with Phosphoribosyl Pyrophosphate Amidotransferase. Journal of Biological Chemistry (1963).
  3. Human Glutamine Phosphoribosylpyrophosphate Amidotransferase KINETIC AND REGULATORY PROPERTIES. Journal of Biological Chemistry (1973).
  4. Human Glutamine Phosphoribosylpyrophosphate Amidotransferase TWO MOLECULAR FORMS INTERCONVERTIBLE BY PURINE RIBONUCLEOTIDES AND PHOSPHORIBOSYLPYROPHOSPHATE. Journal of Biological Chemistry (1973).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.